Proviron

Mesterolone is a 1-methylated dihydrotestosterone (DHT) derivative with unique pharmacological characteristics that set it apart from virtually every other oral anabolic steroid. Developed by Schering (now Bayer) and marketed as Proviron since 1934, it is one of the oldest anabolic steroids still in clinical use. Unlike most oral steroids, Mesterolone is not C17-alpha-alkylated — it achieves oral bioavailability through its 1-methyl modification, which confers resistance to first-pass hepatic metabolism without the liver toxicity associated with 17-alpha-alkylation. This makes Proviron one of the safest oral steroids from a hepatic standpoint.

Mesterolone's primary mechanisms are threefold. First, it binds with extremely high affinity to sex hormone-binding globulin (SHBG), displacing testosterone and other androgens from this carrier protein and thereby increasing the proportion of free (bioactive) testosterone in circulation. This SHBG-binding effect makes every other androgen in a stack functionally more potent. Second, Mesterolone acts as a moderate aromatase inhibitor — it does not directly inhibit the enzyme like Anastrozole, but its DHT-derivative status means it competes with testosterone for the aromatase enzyme, reducing overall estrogen conversion. Third, as a pure androgen, it enhances libido, mood, cognitive sharpness, and subjective well-being — effects researchers frequently describe as a noticeable "quality of life" improvement during administration.

Proviron is the utility player of anabolic pharmacology. It is not used for mass building or dramatic physique transformation. Its value lies in its ability to enhance the efficacy of other compounds, improve the androgenic-to-estrogenic ratio in a stack, maintain libido and mood (particularly on cycles involving 19-nor compounds like Deca or Trenbolone that can impair sexual function), and contribute a mild hardening and drying effect to the physique. Competitive bodybuilders often include it in pre-contest stacks for its cosmetic anti-estrogenic properties.

Proviron is appropriate for all experience levels as an adjunctive compound. It is particularly valuable for researchers experiencing low libido or flat mood on cycle, those running Nandrolone-based compounds (where DHT supplementation can offset "Deca dick"), and researchers who want mild estrogenic control without the potency (and risks) of a pharmaceutical AI. It is one of very few oral steroids considered safe for extended administration.

Mesterolone has a half-life of approximately 12 hours, supporting twice-daily dosing for stable blood levels. Research dosages range from 25–75 mg daily, with 50 mg (split into two 25 mg doses) being the most common. Because it is not C17-alpha-alkylated, hepatotoxicity is negligible — Proviron can be run for 8–12 weeks or longer without liver-support supplementation. It does not suppress the HPTA to a clinically meaningful degree at standard dosages, making it one of the few orals that does not require PCT when used alone at moderate doses. Note: Mesterolone has low oral bioavailability (~3%) — its effectiveness despite this low absorption rate reflects the potency of DHT-class androgens at the receptor level.